alprazolam has been researched along with aniracetam in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Costa, E; DiBella, M; Guidotti, A; Thompson, DM | 1 |
2 other study(ies) available for alprazolam and aniracetam
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.
Topics: Alprazolam; Animals; Benzothiadiazines; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Erythrocebus patas; Female; Learning; Learning Disabilities; Male; Pyrrolidinones; Receptors, GABA-A; Structure-Activity Relationship | 1995 |